Mass Spectrometry Applied to Human Cerebrospinal Fluid Lipidome (II).

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-0716-4462-1_15PMID 40167920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipids as Emerging Biomarkers in Neurodegenerative Diseases

  2023cited by this paper
• Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease

  2023cited by this paper
• Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy

  2022cited by this paper
• Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods

  2020cited by this paper
• Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls

  2018cited by this paper
• Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients

  2018cited by this paper
• Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS

  2017cited by this paper
• Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers

  2017cited by this paper
• Membrane Lipids in Presynaptic Function and Disease.

  2016cited by this paper
• Enhancing metabolomics research through data mining.

  2015cited by this paper
• Lipidomics of human brain aging and Alzheimer's disease pathology.

  2015cited by this paper
• Lipidomic analysis of cerebrospinal fluid by mass spectrometry–based methods

  2015cited by this paper
• Lipidomics: analysis of the lipid composition of cells and subcellular organelles by electrospray ionization mass spectrometry.

  2014cited by this paper
• Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson’s Disease: a Pilot Study

  2013cited by this paper
• Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism

  2012cited by this paper
• Lipidomics at the interface of structure and function in systems biology.

  2011cited by this paper
• Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.

  2010cited by this paper
• Lipidomics: coming to grips with lipid diversity

  2010cited by this paper
• A neuroscientist's guide to lipidomics

  2007cited by this paper
• Centering, scaling, and transformations: improving the biological information content of metabolomics data

  2006cited by this paper

• No citing papers are available for this paper.